Key result
Individualized diet and enalapril achieve target BP in ~84% of hypertensive patients at 12 weeks.
Why the study?
Unhealthy diet is a major modifiable risk factor for CVDs, but standard diets do not account for individual patient characteristics, which may limit their effectiveness in patients with CHD, arterial hypertension, and overweight or obesity.
Does individualized diet therapy combined with lifestyle modification, physical activity, and enalapril improve blood pressure and anthropometric parameters in patients with coronary heart disease and arterial hypertension associated with overweight and obesity?
Cohort (n=244)
Does individualized diet therapy combined with lifestyle modification, physical activity, and enalapril improve blood pressure and anthropometric parameters in patients with coronary heart disease and arterial hypertension associated with overweight and obesity?
Answers are grounded in this paper and cite their sources.
A 12-week regimen of individualized diet therapy, lifestyle modification, and enalapril significantly reduced blood pressure and body weight, achieving target blood pressure in 84% of overweight or obese patients with coronary heart disease and hypertension.
Background. Cardiovascular diseases (CVDs) remain the leading cause of death worldwide, and unhealthy diet is one of their main modifiable risk factors. Standard diets do not take the individual characteristics of the patient into account, which may limit their effectiveness. Aim. To evaluate the effectiveness of individualized diet therapy in patients with coronary heart disease (CHD) and arterial hypertension associated with overweight and obesity. Methods. The study included 244 patients (73 men and 171 women) aged 26–70 years with CHD and grade 1–2 arterial hypertension associated with overweight or obesity. Disease duration was 1–23 years (mean 10 ± 2.4 years). Patients underwent clinical, laboratory, electrocardiographic and anthropometric assessment, blood pressure measurement and evaluation of physical activity. Dietary intake was assessed from a detailed dietary history recorded in an Individual Dietary Status Card. All patients received individualized diet therapy combined with lifestyle modification, regular physical activity and enalapril. Parameters were assessed at baseline and after 12 weeks. Results. At baseline, the diet was characterized by excessive energy intake, a high consumption of fats, meat products, confectionery and sodium, and a low consumption of fish and dietary fiber (11.3 g/day). After 12 weeks, systolic blood pressure decreased by 21% and diastolic blood pressure by 18%. Body weight and BMI decreased by 5.7% in men and 6.2% in women, and waist and hip circumference also decreased. Greater physical activity was associated with larger reductions in anthropometric parameters, and physical activity correlated with the reduction in diastolic blood pressure (r = 0.21; p < 0.05). Target blood pressure (<140/90 mmHg) was achieved in 84% of patients. Conclusion. Individualized diet therapy combined with lifestyle modification and enalapril for 12 weeks was associated with significant reductions in blood pressure, BMI, atherogenic index and serum cholesterol in patients with CHD, arterial hypertension and excess body weight.
No takes yet. Share an insight, caveat, or question.
Zairovna et al. (2026) conducted a cohort in Coronary heart disease and grade 1-2 arterial hypertension associated with overweight or obesity (n=244). Individualized diet therapy combined with lifestyle modification, regular physical activity, and enalapril was evaluated on Target blood pressure (<140/90 mmHg) achievement and changes in blood pressure and anthropometric parameters at 12 weeks. Individualized diet therapy with lifestyle modification and enalapril decreased systolic BP by 21% and diastolic BP by 18%, achieving target BP (<140/90 mmHg) in 84% of patients at 12 weeks.
Synapse has enriched 10 related papers. Consider them for comparative context: